IS8321A - Stöðug afbrigði tegaseródvetnismaleats - Google Patents

Stöðug afbrigði tegaseródvetnismaleats

Info

Publication number
IS8321A
IS8321A IS8321A IS8321A IS8321A IS 8321 A IS8321 A IS 8321A IS 8321 A IS8321 A IS 8321A IS 8321 A IS8321 A IS 8321A IS 8321 A IS8321 A IS 8321A
Authority
IS
Iceland
Prior art keywords
tegaserodhydrogenism
maleate
continuous variant
variant
continuous
Prior art date
Application number
IS8321A
Other languages
English (en)
Inventor
Pfeffer Sabine
Vitzling Christian
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34135099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8321(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IS8321A publication Critical patent/IS8321A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Glass Compositions (AREA)
  • Liquid Crystal Substances (AREA)
  • Indole Compounds (AREA)
IS8321A 2003-07-24 2006-02-22 Stöðug afbrigði tegaseródvetnismaleats IS8321A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48963803P 2003-07-24 2003-07-24
PCT/EP2004/008281 WO2005014544A1 (en) 2003-07-24 2004-07-23 Stable modifications of tegaserod hydrogen maleate

Publications (1)

Publication Number Publication Date
IS8321A true IS8321A (is) 2006-02-22

Family

ID=34135099

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8321A IS8321A (is) 2003-07-24 2006-02-22 Stöðug afbrigði tegaseródvetnismaleats

Country Status (24)

Country Link
US (1) US20070112056A1 (is)
EP (2) EP1880992A1 (is)
JP (1) JP2006528609A (is)
KR (1) KR20060040710A (is)
CN (1) CN1826318A (is)
AR (1) AR045081A1 (is)
AU (1) AU2004263285A1 (is)
BR (1) BRPI0412830A (is)
CA (1) CA2532351A1 (is)
CO (1) CO5680418A2 (is)
EC (1) ECSP066306A (is)
IL (1) IL172914A0 (is)
IS (1) IS8321A (is)
MA (1) MA27935A1 (is)
MX (1) MXPA06000917A (is)
MY (1) MY137386A (is)
NO (1) NO20060915L (is)
NZ (1) NZ544596A (is)
PE (1) PE20050253A1 (is)
RU (1) RU2349585C2 (is)
SG (1) SG144944A1 (is)
TN (1) TNSN06024A1 (is)
TW (1) TW200510302A (is)
WO (1) WO2005014544A1 (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060128788A1 (en) * 2004-10-19 2006-06-15 Santiago Ini Purification of tegaserod maleate
BRPI0606898A2 (pt) * 2005-01-31 2009-07-21 Novartis Ag uso de agonista de 5-ht4 na preparação de medicamentos e método útil no esvaziamento gástrico retardado
CZ298399B6 (cs) * 2005-05-02 2007-09-19 Zentiva, A. S. Zpusob prípravy 2-[(5-methoxy-1 H-indol-3-yl) methylen]-N-pentylkarbazimidamidu (tegaserodu)
KR20070062504A (ko) * 2005-06-22 2007-06-15 테바 파마슈티컬 인더스트리즈 리미티드 테가세로드 말레이트의 다형태
AR058078A1 (es) * 2005-10-06 2008-01-23 Medichem Sa Maleato de tegaserod y procesos de obtencion
GB0524668D0 (en) * 2005-12-02 2006-01-11 Novartis Ag Organic compounds
WO2007120924A1 (en) * 2006-04-17 2007-10-25 Teva Pharmaceutical Industries Ltd. Preparation of tegaserod maleate free of iodide
EP1956002A1 (en) * 2007-02-07 2008-08-13 Chemo Ibérica, S.A. New tegaserod maleate polymorphs and process for their preparation
CA2687209A1 (en) * 2007-05-17 2008-11-27 Generics (Uk) Limited Process for the preparation of form a of tegaserod

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01242588A (ja) * 1988-03-25 1989-09-27 Chiba Gosei Kenkyusho:Kk ７―シアノメチルチオアセトアミド―７α―メトキシ―３―（１―メチル―１Ｈ―テトラゾール―５―イル）チオメチル―３―セフェム―４―カルボン酸の結晶及びその製造方法
GB9106179D0 (en) * 1991-03-22 1991-05-08 Sandoz Ltd Improvements in or relating to organic compounds
HUT64023A (en) * 1991-03-22 1993-11-29 Sandoz Ag Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
JPH08291140A (ja) * 1995-04-20 1996-11-05 Teikoku Chem Ind Corp Ltd 易吸収性結晶
CN1165293C (zh) * 1998-08-21 2004-09-08 诺瓦提斯公司 5ht4激动剂或拮抗剂的新型口服制剂
EP1321142A1 (en) * 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod
CN1176077C (zh) * 2003-01-07 2004-11-17 江苏省药物研究所 马来酸替加色罗一水结晶
WO2004085393A1 (en) * 2003-03-25 2004-10-07 Hetero Drugs Limited Novel crystalline forms of tegaserod maleate
US20050165085A1 (en) * 2003-12-16 2005-07-28 Marioara Mendelovici Polymorphic forms of tegaserod base and salts thereof
US20050272802A1 (en) * 2004-04-22 2005-12-08 Sundaram Venkataraman Process for preparing form I of tegaserod maleate
KR20070062504A (ko) * 2005-06-22 2007-06-15 테바 파마슈티컬 인더스트리즈 리미티드 테가세로드 말레이트의 다형태

Also Published As

Publication number Publication date
AR045081A1 (es) 2005-10-12
CN1826318A (zh) 2006-08-30
TNSN06024A1 (en) 2007-10-03
PE20050253A1 (es) 2005-06-03
NZ544596A (en) 2009-01-31
TW200510302A (en) 2005-03-16
MA27935A1 (fr) 2006-06-01
JP2006528609A (ja) 2006-12-21
MXPA06000917A (es) 2006-03-30
CO5680418A2 (es) 2006-09-29
RU2349585C2 (ru) 2009-03-20
AU2004263285A1 (en) 2005-02-17
EP1880992A1 (en) 2008-01-23
RU2006105481A (ru) 2007-09-20
WO2005014544A1 (en) 2005-02-17
KR20060040710A (ko) 2006-05-10
BRPI0412830A (pt) 2006-09-26
EP1651601A1 (en) 2006-05-03
ECSP066306A (es) 2006-07-28
SG144944A1 (en) 2008-08-28
NO20060915L (no) 2006-04-24
US20070112056A1 (en) 2007-05-17
CA2532351A1 (en) 2005-02-17
IL172914A0 (en) 2006-06-11
MY137386A (en) 2009-01-30

Similar Documents

Publication Publication Date Title
EP1642377A4 (en) VIBRATION DEVICE
DE602004018654D1 (de) Se
EP1500371A4 (en) ULTRASOUND DEVICE
EP1665987A4 (en) ULTRASOUND DEVICE
EP1477118A4 (en) ULTRASOUND DEVICE
AT502792A5 (de) Düsenanpressvorrichtung
IS8321A (is) Stöðug afbrigði tegaseródvetnismaleats
DE602004019555D1 (de) Heterocyclische 7-aminoalkylidenylchinolone und -naphthyridone
DK1597171T3 (da) Terapeutisk mikroskum
DE50201278D1 (de) Stopfpickel
DE50205514D1 (de) Stopfpickel
EP1500370A4 (en) Ultrasonograph
ATA662003A (de) Trink-mundstück
DE502004011589D1 (de) Silylierte carboxamide
DE50309138D1 (de) Stopfaggregat
DE10394144D2 (de) Duschvorrichtung
FR2840006B1 (fr) Construction demontable
AT500001B8 (de) Münzscheideeinrichtung
AT6592U3 (de) Frontgrubber
ATA80232004A (de) Kurbelgehäuse
SE0303358D0 (sv) Plattor
FI5943U1 (fi) Vesiallas
ES1054885Y (es) Faldon derivaaguas
UA8265S (uk) Спідниця
SE0303412D0 (sv) Modes of operation